FP
IRMD icon

Foundry Partners’s iRadimed IRMD Stock Holding History

Foundry Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-62,225
Closed -$2.09M – 366
2021
Q3 		$2.09M Sell
62,225
-11,945
-16% -$406K 0.08% 245
2021
Q2 		$2.18M Sell
74,170
-14,325
-16% -$395K 0.07% 251
2021
Q1 		$2.28M Sell
88,495
-3,520
-4% -$84.1K 0.08% 262
2020
Q4 		$2.1M Buy
92,015
+3,990
+5% +$92.2K 0.08% 280
2020
Q3 		$1.88M Buy
88,025
+14,035
+19% +$315K 0.09% 257
2020
Q2 		$1.72M Buy
+73,990
New +$1.59M 0.08% 259

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
RCG
Resource Consulting Group Orlando, Florida $584M AUM 15.38% 1-Year Est. Return

Foundry Partners's IRMD Position: Q4 2021 in Review

Foundry Partners sold out of iRadimed (IRMD) in Q4 2021, closing a stake of 62,225 shares — an estimated $2.09M sold.

Foundry Partners first reported a position in IRMD in Q2 2020 and held it in 6 quarters. The position peaked at $2.28M in Q1 2021. 96 funds tracked by Wall St. Rank hold IRMD as of Q4 2021.

  • Foundry Partners reported no remaining iRadimed position as of Q4 2021 after selling out during the quarter.
  • Foundry Partners sold 62,225 iRadimed shares in Q4 2021, an estimated $2.09M.
  • Foundry Partners first reported a position in iRadimed in Q2 2020 and held it in 6 quarters.
  • Foundry Partners's iRadimed position peaked at $2.28M in Q1 2021.
  • 96 funds tracked by Wall St. Rank held iRadimed as of Q4 2021.

Based on Foundry Partners's 13F filing for Q4 2021, filed 26 Jan 2022.